US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Oncology Institute

3.62

-3.0800-45.97%

Post-market: 3.630.0100+0.28%19:57 EST

Volume:23.92M

Turnover:98.53M

Market Cap:368.94M

PE:-11.90

High:6.43

Open:6.06

Low:3.35

Close:6.70

52wk High:7.13

52wk Low:2.32

Shares:101.92M

Float Shares:88.60M

Volume Ratio:15.60

T/O Rate:26.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3042

EPS(LYR):-0.5445

ROE:--

ROA:-7.48%

PB:-9.88

PE(LYR):-6.65

Loading ...

Overview Company News Filings

Starling Oncology Down over 41%, on Pace for Record Percent Decrease

Starling Oncology price target lowered to $10 from $11 at B. Riley

Starling Oncology is Maintained at Buy by BTIG

Starling Oncology, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary

Starling Oncology Q3 Operating Loss Narrows 63% Year over Year to $2.98 Million

Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate

Benzinga Earnings

Starling Oncology Q3 Net Income USD -15.7 Million

Starling Oncology Outlook FY Revenue USD 650-660 Million

THOMSON REUTERS

Starling Oncology Q3 EPS USD -0.13

THOMSON REUTERS

Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

Starling Oncology Updates Financial Calendar

Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call

Starling Oncology, Inc. : Needham Raises Target Price to $9 from $7

THOMSON REUTERS

Esquire Financial Holdings And 2 Other Growth Companies With Strong Insider Ownership

Simply Wall St.

Starling Oncology Highlights Leadership Participation at Deutsche Bank 2026 Healthcare Summit

Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million

Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing

THOMSON REUTERS

Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing

THOMSON REUTERS

Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027

Starling Oncology Director Brad Hively Reports Sale of 298,853 Common Shares Worth $1.95 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/stock/STLN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"STLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":3.62,"timestamp":1793998800000,"preClose":6.7,"halted":0,"volume":23917528,"hourTrading":{"tag":"盘后","latestPrice":3.63,"preClose":3.62,"latestTime":"19:57 EST","volume":94518,"amount":345832.7733,"timestamp":1794013078999,"change":0.01,"changeRate":0.002762,"amplitude":0.055249},"delay":0,"changeRate":-0.4597014925373134,"floatShares":88601299,"shares":101916100,"eps":-0.304237,"marketStatus":"Market Closed","change":-3.08,"latestTime":"11-06 16:00:00 EST","open":6.06,"high":6.43,"low":3.3509,"amount":98526869.37937601,"amplitude":0.459567,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.304237,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":6.7,"preHourTrading":{"tag":"盘前","latestPrice":6.07,"preClose":6.7,"latestTime":"09:29 EST","volume":62967,"amount":370841.66560019995,"timestamp":1793975399999,"change":-0.63,"changeRate":-0.09403,"amplitude":0.132687},"postHourTrading":{"tag":"盘后","latestPrice":3.63,"preClose":3.62,"latestTime":"19:57 EST","volume":94518,"amount":345832.7733,"timestamp":1794013078999,"change":0.01,"changeRate":0.002762,"amplitude":0.055249},"volumeRatio":15.599243750317926,"optionData":{"bulkOrders":[{"symbol":"STLN","call":true,"expireDate":1795150800000,"strike":"4.0","timestamp":1793997960360,"price":0.05,"volume":5000,"amount":25000,"type":"-"},{"symbol":"STLN","call":true,"expireDate":1795150800000,"strike":"4.0","timestamp":1793997960360,"price":0.1,"volume":5000,"amount":50000,"type":"+"}]},"impliedVol":1.9288,"impliedVolPercentile":0.9853},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","floatShares":88601299,"roa":"-7.48%","roe":"--","lyrEps":-0.544488,"volumeRatio":15.599243750317926,"shares":101916100,"dividePrice":0,"high":6.43,"amplitude":0.459567,"preClose":6.7,"low":3.3509,"week52Low":2.32,"pbRate":"-9.88","psRate":"0.59","week52High":7.13,"institutionHeld":0,"latestPrice":3.62,"eps":-0.304237,"divideRate":0,"volume":23917528,"delay":0,"ttmEps":-0.304237,"open":6.06,"prevYearClose":3.56,"prevWeekClose":6.53,"prevMonthClose":6.53,"prevQuarterClose":6.32,"fiveDayClose":6.53,"twentyDayClose":6.63,"sixtyDayClose":6.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-11-05","symbol":"STLN","fiscalQuarterEnding":"2026/09","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1793854800000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2026-08-06","symbol":"STLN","fiscalQuarterEnding":"2026/06","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-05-06","symbol":"STLN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778097600000,"name":null,"time":"Post-Mkt","dateTimestamp":1778040000000,"actualEps":null},{"market":"US","date":"2026-03-12","symbol":"STLN","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-11-13","symbol":"STLN","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1783918800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STLN","date":"2026-10-14","current":-11.898619,"percent":0.1,"low":-19.797443,"twenty":-18.618021,"median":-17.803658,"eighty":-17.298192,"high":-11.557791,"avg":-17.541793,"sd":1.72207,"marketCap":682837970},"quantilePoints":[{"date":"2026-08-07","current":-13.746861,"twenty":-12.626432,"median":-11.833524,"eighty":-11.695657,"marketCap":498914835},{"date":"2026-08-14","current":-17.579006,"twenty":-17.646402,"median":-17.298192,"eighty":-11.842715,"marketCap":637994879},{"date":"2026-08-21","current":-18.365288,"twenty":-18.045159,"median":-17.64921,"eighty":-12.999908,"marketCap":666531392},{"date":"2026-08-28","current":-17.803658,"twenty":-18.129404,"median":-17.719414,"eighty":-15.827113,"marketCap":646148169},{"date":"2026-09-04","current":-16.764643,"twenty":-18.045159,"median":-17.487741,"eighty":-16.646701,"marketCap":608439206},{"date":"2026-09-11","current":-17.410518,"twenty":-17.988996,"median":-17.494762,"eighty":-16.66355,"marketCap":631879913},{"date":"2026-09-18","current":-18.618021,"twenty":-18.137828,"median":-17.663251,"eighty":-16.714097,"marketCap":675703842},{"date":"2026-09-25","current":-18.281043,"twenty":-18.354055,"median":-17.733455,"eighty":-16.899434,"marketCap":663473908},{"date":"2026-10-02","current":-17.45264,"twenty":-18.398986,"median":-17.747495,"eighty":-17.146551,"marketCap":633408654},{"date":"2026-10-09","current":-17.354355,"twenty":-18.398986,"median":-17.747495,"eighty":-17.247645,"marketCap":629841590},{"date":"2026-10-14","current":-18.814592,"twenty":-18.618021,"median":-17.803658,"eighty":-17.298192,"marketCap":682837970}],"updateTime":1794049118359},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"STLN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2681899438","title":"Starling Oncology Down over 41%, on Pace for Record Percent Decrease","url":"https://stock-news.laohu8.com/highlight/detail?id=2681899438","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681899438?lang=en_us&edition=fundamental","pubTime":"2026-11-07 02:57","pubTimestamp":1793991420,"startTime":"0","endTime":"0","summary":"Starling Oncology Inc.  is currently at $3.94, down $2.76 or 41.21%--Would be lowest close since May 6, 2026, when it closed at $3.80--Would be largest percent decrease on record --Currently down two consecutive days; down 43.25% over this period--Worst two day stretch on record --Down 39.68% this week; worst weekly performance since the week ending March 17, 2023, when it fell 52.14%--Up 10.64% year-to-date--Down 65.11% from its all-time closing high of $11.29 on Feb. 19, 2021--Up 11.11% from 52 weeks ago , when it closed at $3.55--Down 44.13% from its 52-week closing high of $7.05 on Sept. 22, 2026--Up 65.14% from its 52-week closing low of $2.39 on Feb. 12, 2026--Traded as low as $3.90; lowest intraday level since May 18, 2026, when it hit $3.88--Down 41.79% at today's intraday low; largest intraday percent decrease on record All data as of 1:55:55 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681301862","title":"Starling Oncology price target lowered to $10 from $11 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2681301862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681301862?lang=en_us&edition=fundamental","pubTime":"2026-11-06 22:01","pubTimestamp":1793973666,"startTime":"0","endTime":"0","summary":"B. Riley lowered the firm’s price target on Starling Oncology (STLN) to $10 from $11 and keeps a Buy rating on the shares following the Q3 report. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/starling-oncology-price-target-lowered-to-10-from-11-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/starling-oncology-price-target-lowered-to-10-from-11-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681857190","title":"Starling Oncology is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2681857190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681857190?lang=en_us&edition=fundamental","pubTime":"2026-11-06 18:46","pubTimestamp":1793961960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/STLN/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681880097","title":"Starling Oncology, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681880097","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681880097?lang=en_us&edition=fundamental","pubTime":"2026-11-06 10:30","pubTimestamp":1793932225,"startTime":"0","endTime":"0","summary":"Starling Oncology, Inc. reports results for the quarter ended September 30 - Earnings SummaryStarling Oncology, Inc.STLN.OQreported a quarterly adjusted loss of 13 cents per share for the quarter ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nL5N46N07K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681888240","title":"Starling Oncology Q3 Operating Loss Narrows 63% Year over Year to $2.98 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681888240","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681888240?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:57","pubTimestamp":1793915847,"startTime":"0","endTime":"0","summary":"Starling Oncology Q3 operating loss narrows 63% year over year to $2.98 millionStarling Oncology’s third-quarter 2026 net loss narrowed year over year to $15.75 million.Revenue climbed 24% year over y","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nNDL7SfQK0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4588","BCDF","LU2210150020.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","SG9999014005.SGD","BK4112","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","BK4585","BK4185","SG9999014021.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","SG9999014039.USD","LU2095319765.USD","LU0314104364.USD","LU2210149790.SGD","STLN","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681007602","title":"Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681007602","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681007602?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:18","pubTimestamp":1793913494,"startTime":"0","endTime":"0","summary":"Starling Oncology (NASDAQ:STLN) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.05) by 160 percent. This is a 7.14 percent increase over losses of $(0.14) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/11/62952237/starling-oncology-q3-eps-0-13-misses-0-05-estimate-sales-169-767m-beat-169-047m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Starling Oncology Q3 EPS $(0.13) Misses $(0.05) Estimate, Sales $169.767M Beat $169.047M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681002351","title":"Starling Oncology Q3 Net Income USD -15.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681002351","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681002351?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:07","pubTimestamp":1793912869,"startTime":"0","endTime":"0","summary":"BRIEF-Starling Oncology Q3 Net Income USD -15.7 MillionNov 05 (Reuters) - Starling Oncology Q3 gross profit USD 30.7 million.Q3 EPS USD -0.13","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLX2WJQ0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681883719","title":"Starling Oncology Outlook FY Revenue USD 650-660 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2681883719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681883719?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:06","pubTimestamp":1793912809,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLX2WJQ0K:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681004787","title":"Starling Oncology Q3 EPS USD -0.13","url":"https://stock-news.laohu8.com/highlight/detail?id=2681004787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681004787?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:06","pubTimestamp":1793912809,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nPLX2WJQ0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681889718","title":"Starling Oncology Reports Third Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2681889718","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681889718?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:06","pubTimestamp":1793912760,"startTime":"0","endTime":"0","summary":"CERRITOS, Calif., Nov.  05, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ: STLN) (“STLN” or the “Company”), one of the largest value-based community oncology groups in the United States, to","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/05/3397106/0/en/starling-oncology-reports-third-quarter-2026-financial-results-and-updates-full-year-2026-guidance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLR","STLN","BK4185","BK4149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678196898","title":"Starling Oncology Updates Financial Calendar","url":"https://stock-news.laohu8.com/highlight/detail?id=2678196898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678196898?lang=en_us&edition=fundamental","pubTime":"2026-10-26 21:04","pubTimestamp":1793019893,"startTime":"0","endTime":"0","summary":"Starling Oncology updates financial calendarStarling Oncology will release third-quarter 2026 financial results on Nov. 5, 2026.A conference call with a simultaneous webcast will follow at 5 p.m. East","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDL4Yd6ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3C00.GBP","LU0314104364.USD","NDAQ","BK4588","IE00BN0W2T93.GBP","IE00BQXX3F31.USD","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","BCDF","LU2210150020.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","SG9999014005.SGD","LU2095319765.USD","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014039.USD","STLN","IE00B3QW5Z07.USD","BK4112","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BQXX3D17.EUR","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678677196","title":"Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2678677196","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678677196?lang=en_us&edition=fundamental","pubTime":"2026-10-26 21:00","pubTimestamp":1793019600,"startTime":"0","endTime":"0","summary":"CERRITOS, Calif., Oct.  26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (“STLN”) (NASDAQ: STLN) a pioneer in value-based community oncology care, today announced that the company will release its","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/26/3388126/0/en/starling-oncology-announces-third-quarter-2026-earnings-release-date-and-conference-call.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675312263","title":"Starling Oncology, Inc. : Needham Raises Target Price to $9 from $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2675312263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675312263?lang=en_us&edition=fundamental","pubTime":"2026-10-14 17:04","pubTimestamp":1791968684,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261014:nFWN4600XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675135171","title":"Esquire Financial Holdings And 2 Other Growth Companies With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2675135171","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675135171?lang=en_us&edition=fundamental","pubTime":"2026-10-13 19:05","pubTimestamp":1791889532,"startTime":"0","endTime":"0","summary":"In the last week, the U.S. market has stayed flat, yet over the past 12 months, it has experienced a notable rise of 14%, with earnings expected to grow by 17% annually. In such an environment, growth companies with strong insider ownership can be particularly appealing as they often reflect confidence from those closest to the business in its potential for future success.","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice2-card/1789024931030","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice2-card/1789024931030"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-stln/starling-oncology/news/esquire-financial-holdings-and-2-other-growth-companies-with","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-stln/starling-oncology/news/esquire-financial-holdings-and-2-other-growth-companies-with","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","STLN","BK4116","CMRC","BK4185","ESQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672644137","title":"Starling Oncology Highlights Leadership Participation at Deutsche Bank 2026 Healthcare Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2672644137","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672644137?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:15","pubTimestamp":1790885714,"startTime":"0","endTime":"0","summary":"Starling Oncology highlights leadership participation at Deutsche Bank 2026 Healthcare SummitStarling Oncology leadership highlighted recent participation in major value-based oncology conferences, ci","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLcbZD74:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4585","SG9999014013.SGD","SG9999014039.USD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014021.USD","BK4112","IE00BQXX3C00.GBP","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","SG9999014005.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","STLN","IE00B64PRP62.GBP","BK4185","BK4588","BCDF","IE00BGHQF748.EUR","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582310","title":"Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582310","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582310?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:38","pubTimestamp":1788950292,"startTime":"0","endTime":"0","summary":"Starling Oncology forecasts FY2026 revenue of $650-670 millionStarling Oncology forecast FY26 revenue of USD 650-670 million, based on guidance reiterated in its Aug. 6, 2026 2Q26 release.Adjusted EBI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL1fb2rf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818219","title":"Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818219","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818219?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664182148","title":"Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664182148","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664182148?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818291","title":"Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818291","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818291?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343526,"startTime":"0","endTime":"0","summary":"Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027Starling Oncology director Brad Hively will not stand for re-election at the 2027 annual stockholders ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL98mpdb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662209372","title":"Starling Oncology Director Brad Hively Reports Sale of 298,853 Common Shares Worth $1.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662209372","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662209372?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:11","pubTimestamp":1787605916,"startTime":"0","endTime":"0","summary":"Starling Oncology director Brad Hively reports sale of 298,853 common shares worth $1.95 millionStarling Oncology director Brad Hively sold 298,853 common shares on Aug. 21, 2026 at a weighted average","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4g4JlJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Starling Oncology Director Brad Hively Reports Sale of 298,853 Common Shares Worth $1.95 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}